Ring Therapeutics Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Ring Therapeutics is a Cambridge, Massachusetts-based biotechnology research company focused on gene therapy. It was founded by Flagship Pioneering to advance the field through its commensal virome platform. In 2023, the company partnered with Johns Hopkins University to test antigenicity of AV surface-expressed peptides. In May 2025, Ring Therapeutics presented data at the ASCGT Conference in New Orleans showing that its vector constructs produced with an in vitro assembly platform demonstrated infectivity and expression. The company also contributed findings at the 28th Annual American Society of Gene & Cell Therapy conference, sharing updates on its manufacturing platform.